EUVIMEDEUVIMED entdecken
Crossref

Therapeutic efficacy of the cyanobacterium Leptolyngbya cf. ectocarpi in experimental toxic hepatitis and inflammatory bowel disease in mice

A. P. Lykov, I. P. Uvarov, E. K. Dolgalev

Сибирский научный медицинский журнал · 21.07.2026 · 46 (3) · 58-70

DOI: 10.18699/ssmj20260306 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Сибирский научный медицинский журнал, online erschienen am 21.07.2026. Verfasst von A. P. Lykov und 2 weiteren Autor:innen. Die Arbeit nennt 13 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Toxic hepatitis and inflammatory bowel disease are still a medical and social problem in many countries around the world due to their rising incidence, lack of effective treatment options, and need for new therapeutic approaches. Cyanobacteria as a source of nutrients and bioactive compounds represent an alternative treatment method. The aim of the study was to assess the therapeutic potential of intragastric administration of a suspension or extract of raw biomass of the cyanobacterium Leptolyngbya cf. ectocarpi in mice with toxic hepatitis and inflammatory bowel disease. Material and methods . Alcoholic and acetaminophen-induced hepatitis, as well as inflammatory bowel disease, were induced in mice intragastrically with ethanol, acetaminophen, or sodium dextran sulfate, respectively. Treatment was performed with a suspension or extract of the cyanobacterium (given intragastrically) for 7 days before the induction of the pathological process or 30 minutes after it; mice with inflammatory bowel disease were additionally administered cyclophosphamide or prednisolone. Blood bilirubin content, liver aminotransferase activity, and leukocyte number were assessed. Pathomorphological examination and morphometry of liver, small intestine, and large intestine samples were performed. Results and discussion . Administration of the cyanobacterium suspension and extract to mice with alcoholic hepatitis and inflammatory bowel disease led to a decrease in blood leukocyte count compared to the respective control, whereas in the case of acetaminophen-induced liver injury, it led to an increase. When ethanol and paracetamol are used to induce toxic hepatitis, cyanobacteria have been shown to have a hepatoprotective impact by lowering bilirubin content and liver aminotransferase activity. Correction with cyanobacterium suspension and extract revealed alterations in the microarchitecture of the liver, small intestine, and large intestine in cases of inflammatory bowel disease and toxic hepatitis, which affected hepatocyte and sinusoidal volume density, the quantity of binucleated hepatocytes and sinusoidal cells, the depth of crypts, the length of villi, the thickness of the mucous membrane and muscularis, the number of Paneth cells, goblet cells, and intraepithelial cells in the small intestine, and the depth of crypts, the thickness of the submucosal base, and the muscularis in the large intestine. Conclusions . In mouse models of hepatitis and inflammatory bowel disease, the cyanobacterium Leptolyngbya cf. ectocarpi shows hepatoprotective and anti-inflammatory properties.

Zitieren

APA

Lykov, A. P., Uvarov, I. P., & Dolgalev, E. K. (2026). Therapeutic efficacy of the cyanobacterium Leptolyngbya cf. ectocarpi in experimental toxic hepatitis and inflammatory bowel disease in mice. Сибирский научный медицинский журнал, 46(3), 58-70. https://doi.org/10.18699/ssmj20260306

Vancouver

Lykov AP, Uvarov IP, Dolgalev EK. Therapeutic efficacy of the cyanobacterium Leptolyngbya cf. ectocarpi in experimental toxic hepatitis and inflammatory bowel disease in mice. Сибирский научный медицинский журнал. 2026;46(3):58-70. doi:10.18699/ssmj20260306

BibTeX
@article{Lykov2026,
  author = {Lykov, A. P. and Uvarov, I. P. and Dolgalev, E. K.},
  title = {Therapeutic efficacy of the cyanobacterium Leptolyngbya cf. ectocarpi in experimental toxic hepatitis and inflammatory bowel disease in mice},
  journal = {Сибирский научный медицинский журнал},
  year = {2026},
  volume = {46},
  number = {3},
  pages = {58--70},
  doi = {10.18699/ssmj20260306}
}
Kostenlos starten →